Deficiency of the TLR4 analogue RP105 aggravates vein graft disease by inducing a pro-inflammatory response

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wezel, Anouk ^a,b   De Vries, Margreet R ^b,c   Maassen, Johanna M ^a   Kip, Peter ^b   Peters, Erna A ^b,c   Karper, Jacco C ^b,c   Kuiper, Johan ^a   Bot, Ilze ^a,b   Quax, Paul H A ^b,c  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Einthoven Laboratory for Experimental Vascular Medicine   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CCL2 PROTEIN, MOUSE; LEUKOCYTE ANTIGEN; LOW DENSITY LIPOPROTEIN RECEPTOR; LY78 PROTEIN, MOUSE; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL; ATHEROSCLEROSIS; C57BL MOUSE; CELL CULTURE; DEFICIENCY; GENE EXPRESSION; GENETICS; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MACROPHAGE; MAST CELL; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE CELL;

ANIMALS; ANTIGENS, CD; ATHEROSCLEROSIS; CELLS, CULTURED; CHEMOKINE CCL2; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; MACROPHAGES; MAST CELLS; MATRIX METALLOPROTEINASES; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCYTES, SMOOTH MUSCLE; RECEPTORS, LDL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 84964046875     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24248     Document Type: Article

References (38)

1. Frostegard, J. Immunity, atherosclerosis and cardiovascular disease. BMC Med 11, 117 (2013).
2. Une, D., Kulik, A., Voisine, P., Le May, M., & Ruel, M. Correlates of saphenous vein graft hyperplasia and occlusion 1 year after coronary artery bypass grafting: analysis from the CASCADE randomized trial. Circulation 128, S213-8 (2013).
3. Donker, J. M. W., et al. Midterm results of autologous saphenous vein and ePTFE pre-cuffed bypass surgery in peripheral arterial occlusive disease. Vasc Endovascular Surg 45, 598-603 (2011).
4. Al-Sabti, H. A., et al. Saphenous vein graft vs. radial artery graft searching for the best second coronary artery bypass graft. J Saudi Heart Assoc 25, 247-54 (2013).
5. Fitzgibbon, G. M., et al. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 28, 616-26 (1996).
6. Motwani, J. G., & Topol, E. J. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 97, 916-31 (1998).
7. Campeau, L., et al. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. N Engl J Med 311, 1329-32 (1984).
8. Desai, M., et al. Inhibition of neointimal formation and hyperplasia in vein grafts by external stent/sheath. Vasc Med Lond Engl 15, 287-97 (2010).
9. Mitra, A. K., Gangahar, D. M., & Agrawal, D. K. Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia. Immunol Cell Biol 84, 115-24 (2006).
10. Shukla, N., & Jeremy, J. Y. Pathophysiology of saphenous vein graft failure: a brief overview of interventions. Curr Opin Pharmacol 12, 114-20 (2012).
11. De Vries, M. R., et al. Plaque rupture complications in murine atherosclerotic vein grafts can be prevented by TIMP-1 overexpression. PloS One 7, e47134 (2012).
12. Lardenoye, J. H. P., et al. Accelerated atherosclerosis and calcification in vein grafts: a study in APOE 3 Leiden transgenic mice. Circ Res 91, 577-84 (2002).
13. Karper, J. C., et al. Toll-like receptor 4 is involved in human and mouse vein graft remodeling, and local gene silencing reduces vein graft disease in hypercholesterolemic APOE 3Leiden mice. Arterioscler Thromb Vasc Biol 31, 1033-40 (2011).
14. Akashi-Takamura, S., & Miyake, K. TLR accessory molecules. Curr Opin Immunol 20, 420-5 (2008).
15. Miyake, K., Yamashita, Y., Ogata, M., Sudo, T., & Kimoto, M. RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. J Immunol 154, 3333-40 (1995).
16. Divanovic, S., et al. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat Immunol 6, 571-8 (2005).
17. Wezel, A., et al. RP105 deficiency attenuates early atherosclerosis via decreased monocyte influx in a CCR2 dependent manner. Atherosclerosis 238, 132-39 (2015).
18. Robbins, C. S., et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med 19, 1166-72 (2013).
19. Boring, L., Gosling, J., Cleary, M., & Charo, I. F. Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894-7 (1998).
20. De Vries, M. R., et al. Complement factor C5a as mast cell activator mediates vascular remodelling in vein graft disease. Cardiovasc Res 97, 311-20 (2013).
21. Bot, I., et al. Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-Deficient mice. Circulation 115, 2516-25 (2007).
22. Bot, I., et al. Mast cell chymase inhibition reduces atherosclerotic plaque progression and improves plaque stability in ApoE-/-mice. Cardiovasc Res 89, 244-52 (2011).
23. Bot, I., et al. The neuropeptide substance P mediates adventitial mast cell activation and induces intraplaque hemorrhage in advanced atherosclerosis. Circ Res 106, 89-92 (2010).
24. Rao, K. N., & Brown, M. A. Mast cells: multifaceted immune cells with diverse roles in health and disease. Ann N Y Acad Sci 1143, 83-104 (2008).
25. Lagraauw, H. M., et al. Vascular neuropeptide Y contributes to atherosclerotic plaque progression and perivascular mast cell activation. Atherosclerosis 235, 196-203 (2014).
26. Den Dekker, W. K., et al. Mast cells induce vascular smooth muscle cell apoptosis via a toll-like receptor 4 activation pathway. Arterioscler Thromb Vasc Biol 32, 1960-9 (2012).
27. Sandig, H., & Bulfone-Paus, S. TLR signaling in mast cells: common and unique features. Front Immunol 3, 85 (2012).
28. Rastan, A., et al. Stent placement versus balloon angioplasty for the treatment of obstructive lesions of the popliteal artery: a prospective, multicenter, randomized trial. Circulation 127, 2535-41 (2013).
29. Karper, J. C., et al. TLR accessory molecule RP105 (CD180) is involved in post-interventional vascular remodeling and soluble RP105 modulates neointima formation. PloS One 8, e67923 (2013).
30. Karper, J. C., et al. An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation. Arterioscler Thromb Vasc Biol 33, 2810-7 (2013).
31. Bastiaansen, A. J., et al. TLR4 accessory molecule RP105 (CD180) regulates monocyte-Driven arteriogenesis in a murine hind limb ischemia model. PloS One 9, e99882 (2014).
32. Schepers, A., et al. Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo. Arterioscler Thromb Vasc Biol 26, 2063-9 (2006).
33. Eefting, D., et al. Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice. J Vasc Surg 50, 152-60 (2009).
34. Yang, J., et al. RP105 Protects Against Apoptosis in Ischemia/Reperfusion-Induced Myocardial Damage in Rats by Suppressing TLR4-Mediated Signaling Pathways. Cell Physiol Biochem. 36, 2137-48 (2015).
35. Miyake, K., Yamashita, Y., Hitoshi, Y., Takatsu, K., & Kimoto, M. Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells. J Exp Med 180, 1217-24 (1994).
36. Wezel, A., et al. Complement factor C5a induces atherosclerotic plaque disruptions. J Cell Mol Med. 18, 2020-30 (2014).
37. Zhao, Y., et al. Enhanced foam cell formation, atherosclerotic lesion development, and inflammation by combined deletion of ABCA1 and SR-BI in bone marrow-Derived cells in LDL receptor knockout mice on western-Type diet. Circ Res 107, e20-31 (2010).
38. Chomczynski, P., & Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162, 156-9 (1987).